Clinical Trials Browser

OTHER × Positron-Emission Tomography × Clear all

NCT00367666 2026-03-10

Using Diagnostic Tools to Stage Breast Cancer

Phase NA Active not recruiting

Breast Neoplasms

NCT06448208 2026-03-09

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Active not recruiting

Neuroendocrine Tumors

NCT06819475 2026-03-06

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Neoplasms, Muscle Weakness, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

NCT03535545 2026-02-27

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Phase 1 Recruiting

Lung Neoplasms, Pulmonary Fibrosis

NCT05376878 2026-02-23

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Phase 4 Recruiting

Brain Neoplasms, Breast Neoplasms

NCT07416825 2026-02-18

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

NCT03458520 2026-02-09

Pediatric PET/MR Image Registry

LymphoidSarcoma

Lymphoma, Osteosarcoma

NCT05477823 2026-01-28

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT05133440 2026-01-21

A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT05470699 2025-12-17

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

Phase NA Active not recruiting

34 enrolled 6 charts

Prostatic Neoplasms

NCT04069299 2025-12-05

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

Active not recruiting

Carcinoma, Neuroendocrine

NCT07249281 2025-11-25

MR Microstructural Imaging for Prostate Cancer Diagnosis

Prostatic Neoplasms

NCT05844306 2025-11-19

RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

Phase NA Suspended

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06862856 2025-11-13

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Adenocarcinoma, Prostatic Neoplasms

NCT04017819 2025-11-05

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

Phase 1 Suspended

Lung Neoplasms, Neoplasms

NCT06015295 2025-10-24

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

Phase NA Recruiting

Brain Neoplasms

NCT05289193 2025-10-23

CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma

Phase 2 Active not recruiting

Melanoma

NCT06566209 2025-10-15

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Other hematologic neoplasm

Myocarditis, Hematologic Neoplasms

NCT05141643 2025-09-04

Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05737615 2025-09-04

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT06150547 2025-08-12

A Study of Metabolic Agents Following Brain Radiation

Central Nervous System Neoplasms

NCT00935090 2025-07-08

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

CNSDermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Central Nervous System Neoplasms, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis, Intraocular Lymphoma

NCT02810873 2025-05-04

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

Phase NA Terminated

19 enrolled 7 charts

Breast Neoplasms

NCT03824535 2025-04-09

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Phase 2 Completed

15 enrolled 7 charts

Smoking Cessation, Multiple Pulmonary Nodules

NCT05753995 2025-04-01

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

Phase NA Active not recruiting

Glioblastoma

NCT04053842 2025-03-13

IGPC-5

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04510311 2025-01-10

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

Phase EARLY_PHASE1 Completed

Neuroendocrine Tumors

NCT03054792 2024-12-13

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

Phase 1 Enrolling by invitation

Rhabdomyosarcoma, Sarcoma

NCT02023996 2024-12-10

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Phase NA Completed

42 enrolled 11 charts

Gastrointestinal

Esophagogastric Cancer

NCT05632601 2024-11-04

HER-CROWN

Phase NA Recruiting

BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT05662540 2024-10-26

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

Phase NA Recruiting

Lymphoma, Extranodal NK-T-Cell

NCT06586047 2024-09-19

Breast Cancer PSMA PET

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02492867 2024-09-03

A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase NA Completed

49 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT06211803 2024-01-18

JPETClinic

CNSEndocrineNET

Brain Neoplasms, Neuroendocrine Tumors, Neurodegenerative Diseases

NCT02683824 2023-09-21

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Phase EARLY_PHASE1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02809690 2023-09-07

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT03244566 2023-07-13

PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)

Gastrointestinal

Esophageal Neoplasms

NCT04521894 2023-06-09

The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer

Prostatic Neoplasms

NCT04554719 2023-02-14

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Phase NA Unknown

Neoplasms

NCT05006326 2023-02-14

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Phase NA Unknown

Neoplasms

NCT02414750 2022-11-30

REPOSIT

Phase 2 Terminated

Melanoma

NCT05565898 2022-11-01

PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma

Lymphoma

NCT03563482 2022-04-28

Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT03057743 2021-11-18

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

Breast Neoplasms

NCT02469922 2021-07-27

TEmPoRAL

Phase NA Completed

Head and Neck Neoplasms

NCT04348682 2021-06-24

Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging

Approved for marketing

Prostatic Neoplasms

NCT03352037 2021-04-19

18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study

Phase NA Completed

Gastrointestinal

Pancreatic Cystic Neoplasms

NCT03125629 2021-04-09

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Phase 2 Completed

53 enrolled 8 charts

Cancer Diagnosis

NCT02611882 2020-12-22

PSMA PET

Phase 2 Completed

225 enrolled 12 charts

Prostatic Neoplasms